EUVIMEDEUVIMED entdecken
Crossref

Rethinking placebo-controlled clinical trials in psychedelic therapies for psychiatric illness

Amy Lehrner iD, Thomas B Hildebrandt, Rachel Yehuda

The British Journal of Psychiatry · 2025-10 · 227 (4) · 721-722

DOI: 10.1192/bjp.2025.51 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The British Journal of Psychiatry, online erschienen am 21.07.2025. Verfasst von Amy Lehrner und 2 weiteren Autor:innen. Beteiligte Einrichtung: James J Peters VA Medical Center, Bronx, NY, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Randomised clinical trialmethodologyplacebopsychedelicpsychotherapy

Autor:innen und Institutionen

  • James J Peters VA Medical Center, Bronx, NY, USA.
  • Department of Psychiatry, Icahn School of Medicine at Mount Sinai, NY, USA.
  • The Parsons Research Center for Psychedelic Healing, Icahn School of Medicine at Mount Sinai, NY, USA.

ORCID-Profile: Amy Lehrner

Zitieren

APA

Lehrner, A., Hildebrandt, T. B., & Yehuda, R. (2025). Rethinking placebo-controlled clinical trials in psychedelic therapies for psychiatric illness. The British Journal of Psychiatry, 227(4), 721-722. https://doi.org/10.1192/bjp.2025.51

Vancouver

Lehrner A, Hildebrandt TB, Yehuda R. Rethinking placebo-controlled clinical trials in psychedelic therapies for psychiatric illness. The British Journal of Psychiatry. 2025;227(4):721-722. doi:10.1192/bjp.2025.51

BibTeX
@article{Lehrner2025,
  author = {Lehrner, Amy and Hildebrandt, Thomas B and Yehuda, Rachel},
  title = {Rethinking placebo-controlled clinical trials in psychedelic therapies for psychiatric illness},
  journal = {The British Journal of Psychiatry},
  year = {2025},
  volume = {227},
  number = {4},
  pages = {721--722},
  doi = {10.1192/bjp.2025.51}
}
Kostenlos starten →